SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

A bullish Morgan Stanley call and SpaceXs proposed Florida methane pipeline for Starship are driving attention, with traders also focused on an upcoming Starship flight and the companys AI ambitions. Bulls celebrate the momentum, while skeptics cite stretched valuation and upcoming share unlocks as risks.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

A high-volume breakout has drawn attention, with traders linking optimism to Michael Caputos appointment to the Presidents Cancer Panel and speculating it could support broader access to ImmunityBios Anktiva; no such access change is confirmed. The community is also debating whether heavy short interest could amplify the move or whether the rally is momentum-driven without a new company announcement.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Vaccine-sector optimism around reports of a suspected pneumonic-plague outbreak in Russia, alongside a rivals positive late-stage vaccine results, is driving attention to NVAX. Traders debate whether the move is outbreak-related FOMO or reflects Novavaxs partner-led vaccine rollout and could fuel a short squeeze; others caution that Novavax has no plague vaccine and the outbreak claims remain uncertain.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidias push to fresh highs and a breakout above recent resistance is driving attention, alongside broader enthusiasm for AI and chip stocks. Bulls point to continued AI-infrastructure demand, while skeptics warn of stretched valuations, rising yields, light volume and possible profit-taking.

Ginkgo Bioworks Holdings, Inc. engages in developing biological engineering products and custom microbes. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment includes end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through its Canopy and Horizon offerings. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

A sharp rebound and technical breakout have put DNA in focus, with traders tying the move to renewed interest in Ginkgos autonomous-lab and AI-biology strategy, including its Cloud Lab and OpenAI-related developments. Bulls see a potential re-rating, while skeptics question whether the partnerships and lab automation can translate into meaningful revenue amid the companys weak financial track record.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Anticipation around Applied Digitals fiscal Q1 results and guidance is driving discussion, with traders debating whether lease revenue, project progress, or new contract and financing updates can improve sentiment. The confirmed addition of 75 MW at Polaris Forge 1 has reinforced the execution-focused bull case, but many remain frustrated that the shares have struggled amid weakness across data-center stocks and higher-rate concerns.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Discussion centers on Trumps conditional $5,000 payment pledge if Republicans win both chambers, with many traders questioning its legality, funding, and credibility while some defend the proposal. Broader debate ties DJTs prospects to Trumps midterm standing amid criticism of the Iran war, fuel costs, and economic conditions.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as smartphones, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

TSMCs breakout to fresh highs is drawing attention, with traders citing optimism around AI-chip demand and Elon Musks confirmation of preliminary discussions about TSMCs potential role in the Texas Terafab project. The partnership is not finalized, and while many traders see room for the rally to continue, others caution that momentum and volume may be stretched and flag profit-taking risk.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

GRRRs weakness has focused attention on unresolved financing needs and possible dilution, alongside doubts about managements transparency and ability to turn announced AI infrastructure contracts into revenue. Bulls point to Yotta deployment progress and new contract activity, but many traders say they want clearer financing details and proof of execution before confidence improves.

Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering and Jeff Fairman on November 27, 2013, and is headquartered in San Carlos, CA.

Vaxcyte Inc

Vaxcytes VAX-31 met the primary goals in its pivotal Phase 3 adult pneumococcal-vaccine trial, driving a sharp rally as traders highlighted its potential to compete with existing vaccines. The announced equity-and-convertible-notes offering to fund further trials and launch preparation has prompted concerns about dilution, alongside bullish reactions to the clinical results.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

GeneDx Introduces Easy Order at AAP 2026 to Simplify Genomic Testing in Everyday Pediatric Care

GeneDx, the leader in rare disease diagnosis and improving health through the power of genomic data, today announced it will introduce Easy Order at the 2026 American Academy of Pediatrics (AAP) National Conference & Exhibition, October 2-6 in San Diego. The new streamlined experience makes it...

GeneDx and Beren Therapeutics Launch NPC GenomeComplete to Improve Diagnosis of Niemann-Pick Disease Type C

GeneDx, the leader in rare disease diagnosis and improving health through the power of genomic data, today announced a collaboration with Beren Therapeutics P.B.C. to launch the NPC GenomeComplete Sponsored Testing Program. The program provides no-cost comprehensive genome sequencing for eligible...

3 Promising Genomics Stocks in the Spotlight in 2026 

Genomics is reshaping healthcare, with WGS, NEO and NTLA advancing diagnostics and precision medicine.

GeneDx CEO Katherine Stueland Recognized as a 2026 Fierce 50 Honoree

GeneDx, the leader in rare disease diagnosis and improving health through the power of genomic data, today announced Katherine Stueland, CEO of GeneDx, has been named a 2026 Fierce 50 honoree for Health Equity by Fierce Pharma, Fierce Biotech and Fierce Healthcare. The Fierce 50 recognizes 50...

Top Stock Picks for Week of August 24, 2026

A Semiconductor Packaging Company with Strong Financial Momentum and a Medical Services Company with Solid Short-Term Price Momentum.

GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Childrens

GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced new data published in Genetics in Medicine, an official journal of the American College of Medical Genetics and Genomics (ACMG), in collaboration with the clinical...

Can GENEDX HOLDINGS (WGS) Run Higher on Rising Earnings Estimates?

GeneDx Holdings Corp. (WGS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

GeneDx Launches New Online Offering for Families to Improve Accessibility of Exome Testing for Children with Global Developmental Delay, Intellectual Disability and Epilepsy

GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced the launch of a new online offering designed to expand accessibility of exome testing across the U.S. at scale for pediatric patients with global developmental delay...

GeneDx to Participate in Upcoming Investor Conferences

GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced that company management will participate in upcoming investor conferences: Canaccord Genuity 46th Annual Growth Conference Boston, MA Fireside Chat: Tuesday, August 11...

GeneDx Holdings Corp. (WGS) Q2 Earnings and Revenues Surpass Estimates

GENEDX HOLDINGS (WGS) delivered earnings and revenue surprises of +105.26% and +4.32%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

GeneDx Holdings Corp. is a rare disease diagnosis company, with a mission to empower everyone to live their healthiest life through genomics. The firm combines clinical expertise, advanced technology, and the power of GeneDx Infinity. This foundation powers GeneDx's ExomeDx and GenomeDx tests, enabling clinicians to deliver precise, fast, and actionable diagnoses. The Infinity also fuels discovery for biopharma with AI-driven genomic intelligence. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

GeneDx Holdings Corp - Ordinary Shares - Class A

WGS Stock Slumps After Hours As Firm Predicts Lower Test Volume For Year

Equity

Bullish Sentiment

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be this week?

Stocktwits

Stocktwits Polls

GeneDx Holdings Corp

$WGS  Grizzly Research the smae assholes who never proved anything. Rmember XP investments?!!! Good opportunity to buy when the lies settle.

quiet_investor_

$WGS Biotech doing great today and this ticker is still going down.  Not sure what to think of this.  The only negative is the absurd lawsuits due to whiners who lost money and it hurt their egos because institutional investors can't accept they aren't in control of everything.  Can't wait until genomic medicine becomes the norm to see if those investors can still find a way to make mm believable enough to not be sued themselves.

$WGS is ripping, up 5% today and 20% in five days

Crazy momentum

Options traders are diving in with two big Dec 18 26 $90 ITM call buys, totaling $2.2M in premium

Spotted a $1.73M block and a $458k sweep at the ask on InsiderFinance

But with around 80% IV and the stock extended, be careful out there

Post-earnings beat and a “Moderate Buy” rating are keeping the hype alive

Watch those Form 4s from the CFO and CEO

If you're going long, size it right and maybe look for dips instead of chasing highs

$WGS 50 day approaching 200 pushing  up at 100 Fibonacci. Next resistance at 107 level. LFG🚀🚀🚀

Matthew Lorenzen

$WGS looking like even the large holders are not going to stop the bleeding. What a bad week

Emile. Zola

$WGS Such easy money.  If there is any good news regarding WGS growth, you know the stock is going to plummet.  Given yesterday's news report, it is positive for WGS so I bet the stock would go down and sure enough, my cash balance went up a lot today.  Making money off of illogical truths is always fun.

Feed

News

Sentiment

Earnings

Fundamentals

Info

WGS GeneDx Holdings Corp

Fundamentals

Latest WGS News